Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 1.00 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.66 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.66 |
| ▸ | CDK2 | P24941 | 7/20 | 0.61 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.56 |
| ▸ | CDK1 | P06493 | 6/20 | 0.51 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.51 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.51 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.51 |
| ▸ | MGMT | P16455 | 4/20 | 0.50 |
| ▸ | BRAF | P15056 | 2/20 | 0.50 |
| ▸ | PNP | P00491 | 1/20 | 0.50 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.49 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 6-Chloroguanine SCHEMBL9183931 | 0.98 | DPP4 (0.96) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL8715991 | 0.98 | DPP4 (0.96) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL28284949 | 0.98 | DPP4 (0.96) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL9079950 | 0.98 | DPP4 (0.96) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL18985252 | 0.88 | DPP4 (0.78) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL9424255 | 0.87 | DPP4 (0.76) | DPP4PDPK1GDACDK2MAP3K5 | |
| 6-Chloroguanine SCHEMBL17187927 | 0.83 | DPP4 (0.69) | DPP4CDK2CDK1CCNB1CCNA2 | |
| 6-Chloroguanine SCHEMBL9226302 | 0.82 | DPP4 (0.68) | DPP4PDPK1GDACDK2MAP3K5 | |
| SCHEMBL37384 | 0.79 | DPP4 (0.66) | DPP4PDPK1GDA | |
| 2,6-Diaminopurine SCHEMBL24053 | 0.79 | PDPK1 (1.00) | DPP4PDPK1GDACDK2MAP3K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8448 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| US-20250340868-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | STEMCELL TECHNOLOGIES CANADA INC (CA) | 2025-11-06 | — | — | US | claimed |
| EP-4631970-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-4561602-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | Stemcell Technologies Canada Inc. (CA) | 2025-06-04 | — | — | EP | claimed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| US-20250152737-A1 | LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2025-05-15 | — | — | US | claimed |
| CN-119977968-A | N, N-dibenzyl-N' - (6-chloro-6, 9-dihydro-1H-purin-2-yl) formamidine compound and preparation and application thereof | 黄冈鲁班药业股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119977967-A | N-methyl-N-benzyl-N' - (6-chloro-6, 9-dihydro-1H-purin-2-yl) formamidine compound and preparation and application thereof | 黄冈鲁班药业股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119954809-A | Method for separating purine and analogues thereof | 杭州中美华东制药有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119866224-A | Polynucleotide encoding a linking antigen and uses thereof | 加拿大干细胞技术公司 | 2025-04-22 | — | — | CN | claimed |
| EP-0152965-B1 | PROCESS FOR PREPARING 2,6-SUBSTITUTED-9-(1,3-DIHYDROXY-2-PROPOXY-MENTHYL)-PURINES AND CERTAIN DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1990-10-24 | — | — | EP | claimed |
| EP-0391411-A2 | 3'-Substituted methyl nucleosides as antiviral agents | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | claimed |
| EP-0366059-A2 | Carbocyclic nucleoside analogs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-05-02 | — | — | EP | claimed |
| CN-1040978-A | New New cyclobutane derivative and preparation method thereof | NIPPON KAGAKU SANGYO KK (JP) | 1990-04-04 | — | — | CN | claimed |
| EP-0358154-A2 | Novel cyclobutane derivative and process for producing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1990-03-14 | — | — | EP | claimed |
| US-4801710-A | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO., INC. (US) | 1989-01-31 | — | — | US | claimed |
| EP-0260596-A2 | 2-Amino-6-alkoxy-purins substituted in position 9, process for their preparation, their use and pharmaceutical compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-03-23 | — | — | EP | claimed |
| US-4621140-A | Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-11-04 | — | — | US | claimed |
| EP-0184473-A1 | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO. INC. (US) | 1986-06-11 | — | — | EP | claimed |
| EP-0152965-A2 | Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxy-menthyl)-purines and certain derivatives | SYNTEX (U.S.A.) INC. (US) | 1985-08-28 | — | — | EP | claimed |